Sep 17, 2024, 10:07
Richard Sullivan: How NHS adapted Systemic Anti-Cancer Treatments for solid cancers
Richard Sullivan shared a post on X:
“We are still learning from COVID-19 pandemic. A deep analysis of how NHS adapted SACT for solid cancers and the underlying evidence base for these changes.”
Authors: Mark P. Lythgoe, Alica-Joana Emhardt, Huseyin Naci, Jonathan Krell, Richard Sullivan and Ajay Aggarwal.
Source: Richard Sullivan/X
Richard Sullivan is a Professor of Cancer and Global Health at King’s College London, where he directs the King’s Institute of Cancer Policy and co-directs the Conflict and Health Research Group. His research spans from global cancer studies to conflict and health, with a focus on capacity building in conflict zones, humanitarian medicine, women’s health, and digital innovation in surgery.
Ajay Aggarwal
Alica-Joana Emhardt
American Society of Clinical Oncology
ASCO
cancer
cancer awareness
Cancer Policy
COVID-19
COVID-19 pandemic
COVID-19 response
fight against cancer
Global fight against cancer
Huseyin Naci
Jonathan Krell
King’s Institute of Cancer Policy
Lancet
Mark P. Lythgoe
National Health Service
NHS
OncoDaily
Oncology
Richard Sullivan
SACT
Systemic Anti-Cancer Treatments
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Oct 6, 2024, 17:35
Oct 6, 2024, 17:16
Oct 6, 2024, 17:12
Oct 6, 2024, 17:05